- Home
- USFD vs VTRS Comparison
USFD vs VTRS Comparison
Compare USFD & VTRS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- USFD
- VTRS
- Stock Information
- Founded
- USFD 2007
- VTRS 1961
- Country
- USFD United States
- VTRS United States
- Employees
- USFD N/A
- VTRS N/A
- Industry
- USFD Food Distributors
- VTRS Medicinal Chemicals and Botanical Products
- Sector
- USFD Consumer Discretionary
- VTRS Health Care
- Exchange
- USFD Nasdaq
- VTRS Nasdaq
- Market Cap
- USFD 15.8B
- VTRS 14.0B
- IPO Year
- USFD 2016
- VTRS N/A
- Fundamental
- Price
- USFD $68.32
- VTRS $11.30
- Analyst Decision
- USFD Strong Buy
- VTRS Hold
- Analyst Count
- USFD 12
- VTRS 3
- Target Price
- USFD $71.33
- VTRS $13.67
- AVG Volume (30 Days)
- USFD 1.7M
- VTRS 10.6M
- Earning Date
- USFD 02-13-2025
- VTRS 02-26-2025
- Dividend Yield
- USFD N/A
- VTRS 4.25%
- EPS Growth
- USFD 29.12
- VTRS N/A
- EPS
- USFD 2.34
- VTRS N/A
- Revenue
- USFD $37,322,000,000.00
- VTRS $15,048,500,000.00
- Revenue This Year
- USFD $8.54
- VTRS N/A
- Revenue Next Year
- USFD $5.41
- VTRS N/A
- P/E Ratio
- USFD $29.25
- VTRS N/A
- Revenue Growth
- USFD 6.10
- VTRS N/A
- 52 Week Low
- USFD $44.82
- VTRS $9.93
- 52 Week High
- USFD $72.84
- VTRS $13.62
- Technical
- Relative Strength Index (RSI)
- USFD 53.39
- VTRS 28.18
- Support Level
- USFD $67.55
- VTRS $11.13
- Resistance Level
- USFD $68.23
- VTRS $12.02
- Average True Range (ATR)
- USFD 1.11
- VTRS 0.32
- MACD
- USFD 0.02
- VTRS -0.09
- Stochastic Oscillator
- USFD 85.90
- VTRS 10.97
About USFD US Foods Holding Corp.
US Foods Holding Corp is the U.S. food service distributor. us Foods distributes food and nonfood products to the healthcare and hospitality industries, restaurants, and education, government facilities, and grocers. In addition to its delivery business, the firm has 80 cash-and- carry stores under the Chef'Store banner. The company generates majority of the revenue from Meats and seafood products.
About VTRS Viatris Inc.
Viatris was formed in November 2020 through the combination of Upjohn, a wholly owned subsidiary of Pfizer that specialized in off-patent drugs, and Mylan, a global pharmaceutical manufacturer that focused on generic and specialty drugs. By joining forces, Viatris became one of the largest generic drug manufacturers in the world, servicing over 165 countries. Generics (commoditized and complex) and biosimilars make up roughly 40% of Viatris' total sales. Remaining 60% of sales is derived from its portfolio of legacy products which includes Lipitor, Norvasc, Lyrica, and Viagra. While it covers more than 10 major therapeutic areas, Viatris has identified dermatology, ophthalmology, and gastroenterology as its three key areas of focus for future innovations.